EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Anti-hypertensive medications and erectile dysfunction: focus on β-blockers

G Corona, W Vena, A Pizzocaro, G Salvio, C Sparano, A Sforza, M Maggi

Endocrine · 13.09.2024 · 87 (1) · 11-26

DOI: 10.1007/s12020-024-04020-x ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endocrine, online erschienen am 13.09.2024. Verfasst von G Corona und 6 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Maggiore Hospital, Azienda-Usl Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Erectile Dysfunction, Antihypertensive Agents, Adrenergic beta-Antagonists, Hypertension. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Recovery and Resilience Plan, Investment PE8 - Project Age-It: "Ageing Well in an Ageing Society, Recovery and Resilience Plan, Investment PE8 – Project Age-It: “Ageing Well in an Ageing Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although anti-hypertensive medications, including thiazides and β-blockers (BBs) in particular, have been suggested to cause erectile dysfunction (ED) their real contribution is still conflicting. The aim of this paper is to summarize available evidence providing an evidence-based critical analysis of the topic.

Methods

An overall comprehensive narrative review was performed using Medline, Embase and Cochrane search. In addition, to better understand the impact of BBs on ED a specific systematic review was also performed.

Results

The negative role of centrally acting drugs, such as clonidine and α-methyldopa, is well documented althuogh limited controlled trials are available. Angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor blockers (ARBs), and calcium-channel-blockers (CCBs) have neutral (CCBs) or even positive (ACEis and ARBs) effects on erectile function. Despite some preliminary negative reports, more recent evidence does not confirm the negative impact of thiazides. BBs should be still considered the class of medications more often associated with ED, although better outcomes can be drawn with nebivolol.

Conclusion

Sexual function should be assessed in all patients with arterial hypertension, either at diagnosis or after the prescription of specific medications. A close related patient-physician interaction and discussion can overcome possible negative outcomes allowing a successful management of possible side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erectile DysfunctionAntihypertensive AgentsAdrenergic beta-AntagonistsHypertensionHumansMale

Stichwörter der Autor:innen

Antihypertensive medicationsBeta-blockersErectile dysfunctionHypertension

Substanzen

Antihypertensive AgentsAdrenergic beta-Antagonists

Autor:innen und Institutionen

  • Endocrinology Unit, Maggiore Hospital, Azienda-Usl Bologna, Bologna, Italy.
  • Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.
  • Diabetes Center, Humanitas Gavezzani Institute, Bergami, Italy.
  • Unit of Endocrinology, Diabetology and Medical Andrology, IRCSS, Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Endocrinology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.
  • Endocrinology Unit Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Förderung

  • Recovery and Resilience Plan, Investment PE8 - Project Age-It: "Ageing Well in an Ageing Society
  • Recovery and Resilience Plan, Investment PE8 – Project Age-It: “Ageing Well in an Ageing Society

Zitieren

APA

Corona, G., Vena, W., Pizzocaro, A., Salvio, G., Sparano, C., Sforza, A., & Maggi, M. (2024). Anti-hypertensive medications and erectile dysfunction: focus on β-blockers. Endocrine, 87(1), 11-26. https://doi.org/10.1007/s12020-024-04020-x

Vancouver

Corona G, Vena W, Pizzocaro A, Salvio G, Sparano C, Sforza A, et al. Anti-hypertensive medications and erectile dysfunction: focus on β-blockers. Endocrine. 2024;87(1):11-26. doi:10.1007/s12020-024-04020-x

BibTeX
@article{Corona2024,
  author = {Corona, G and Vena, W and Pizzocaro, A and Salvio, G and Sparano, C and Sforza, A and Maggi, M},
  title = {Anti-hypertensive medications and erectile dysfunction: focus on β-blockers},
  journal = {Endocrine},
  year = {2024},
  volume = {87},
  number = {1},
  pages = {11--26},
  doi = {10.1007/s12020-024-04020-x}
}
Kostenlos starten →